Qube Research & Technologies (QRT)’s Inhibrx INBX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$510K	Buy	+5,378	New	+$539K	﹤0.01%	2650
2025 Q3	–	Sell	-19,886	Closed	-$284K	–	3769
2025 Q2	$284K	Sell	19,886 -28,021	-58%	-$362K	﹤0.01%	2832
2025 Q1	$670K	Sell	47,907 -43,314	-47%	-$588K	﹤0.01%	2428
2024 Q4	$1.4M	Sell	91,221 -18,720	-17%	-$285K	﹤0.01%	2028
2024 Q3	$1.72M	Sell	109,941 -31,459	-22%	-$442K	﹤0.01%	1813
2024 Q2	$2M	Buy	+141,400	New	+$2.21M	﹤0.01%	1621

Other funds holding INBX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Qube Research & Technologies (QRT)'s INBX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Inhibrx (INBX) in Q2 2026: 5,378 shares worth $510K. The stake represents ﹤0.01% of the portfolio and ranks #2650 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in INBX as recently as Q2 2025.

Qube Research & Technologies (QRT) first reported a position in INBX in Q2 2024 and has held it in 6 quarters since. The position peaked at $2M in Q2 2024. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

Qube Research & Technologies (QRT) held 5,378 shares of Inhibrx worth $510K as of Q2 2026.
Inhibrx was a new Qube Research & Technologies (QRT) position in Q2 2026.
Inhibrx made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2650 holding.
Qube Research & Technologies (QRT) first reported a position in Inhibrx in Q2 2024 and has held it in 6 quarters since.
Qube Research & Technologies (QRT)'s Inhibrx position peaked at $2M in Q2 2024.
162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.